{
    "ticker": "IMNM",
    "name": "Imunon, Inc.",
    "description": "Imunon, Inc. is a clinical-stage biotechnology company focused on developing novel therapies for cancer and infectious diseases. Founded in 1996 and headquartered in Rockville, Maryland, Imunon is dedicated to advancing immune-oncology treatments using its proprietary platform technologies. The company is working on a range of product candidates, including immunotherapeutics designed to stimulate the immune system to fight cancer more effectively. One of its key programs is focused on developing a therapeutic vaccine for the treatment of cancers such as breast cancer and brain tumors, aiming to harness the body's immune response to target and destroy malignant cells. Imunon also explores the use of its technology in antiviral treatments, showcasing its commitment to addressing critical health challenges. With a robust pipeline and a team of experienced professionals, Imunon is at the forefront of innovation in the biopharmaceutical industry and is committed to improving patient outcomes through cutting-edge research and development. The company is focused on collaboration with researchers and institutions to further its mission of delivering transformative therapies that can change the standard of care in oncology and infectious diseases.",
    "industry": [
        "Biotechnology",
        "Pharmaceuticals"
    ],
    "headquarters": "Rockville, Maryland, USA",
    "founded": "1996",
    "website": "https://www.imunon.com",
    "ceo": "William A. McNulty",
    "social_media": {
        "twitter": "https://twitter.com/ImunonInc",
        "linkedin": "https://www.linkedin.com/company/imunon/"
    },
    "investor_relations": "https://www.imunon.com/investor-relations",
    "key_executives": [
        {
            "name": "William A. McNulty",
            "position": "CEO"
        },
        {
            "name": "David L. S. Hsu",
            "position": "CFO"
        }
    ],
    "product_categories": [
        {
            "category": "Immunotherapy",
            "products": [
                "Therapeutic Vaccines"
            ]
        },
        {
            "category": "Antiviral Treatments",
            "products": [
                "Novel Antiviral Candidates"
            ]
        }
    ],
    "seo": {
        "meta_title": "Imunon, Inc. | Innovative Therapies for Cancer and Infectious Diseases",
        "meta_description": "Explore Imunon, Inc., a biotechnology company dedicated to developing innovative immunotherapies and antiviral treatments to improve patient outcomes.",
        "keywords": [
            "Imunon",
            "Biotechnology",
            "Immunotherapy",
            "Cancer Treatment",
            "Infectious Diseases",
            "Therapeutic Vaccines"
        ]
    },
    "faq": [
        {
            "question": "What does Imunon focus on?",
            "answer": "Imunon focuses on developing novel immunotherapies for cancer and antiviral treatments."
        },
        {
            "question": "Who is the CEO of Imunon?",
            "answer": "William A. McNulty is the CEO of Imunon, Inc."
        },
        {
            "question": "Where is Imunon headquartered?",
            "answer": "Imunon is headquartered in Rockville, Maryland, USA."
        },
        {
            "question": "What are Imunon's main products?",
            "answer": "Imunon's main products include therapeutic vaccines for cancer and novel antiviral candidates."
        },
        {
            "question": "When was Imunon founded?",
            "answer": "Imunon was founded in 1996."
        }
    ],
    "competitors": [
        "MRNA",
        "NVS",
        "BMY",
        "REGN"
    ],
    "related_stocks": [
        "AAPL",
        "AMGN",
        "GILD",
        "VRTX"
    ]
}